Related references
Note: Only part of the references are listed.Target Blood Pressure for Treatment of Isolated Systolic Hypertension in the Elderly Valsartan in Elderly Isolated Systolic Hypertension Study
Toshio Ogihara et al.
HYPERTENSION (2010)
Calcium channel blockers and cardiovascular outcomes: a meta-analysis of 175 634 patients
Pierluigi Costanzo et al.
JOURNAL OF HYPERTENSION (2009)
Reappraisal of European guidelines on hypertension management: a European Society of Hypertension Task Force document
Giuseppe Mancia et al.
JOURNAL OF HYPERTENSION (2009)
Effects of candesartan compared with amlodipine in hypertensive patients with high cardiovascular risks - Candesartan Antihypertensive Survival Evaluation in Japan Trial
Toshio Ogihara et al.
HYPERTENSION (2008)
Benazepril plus Amlodipine or Hydrochlorothiazide for Hypertension in High-Risk Patients
Kenneth Jamerson et al.
NEW ENGLAND JOURNAL OF MEDICINE (2008)
Incident diabetes in clinical trials of anti hypertensive drugs: a network meta-analysis
William J. Elliott et al.
LANCET (2007)
Pharmacological, pharmacokinetic, and clinical properties of benidipine hydrochloride, a novel, long-acting calcium channel blocker
K Yao et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2006)
The Felodipine Event Reduction (FEVER) Study: a randomized long-term placebo-controlled trial in Chinese hypertensive patients
LS Liu et al.
JOURNAL OF HYPERTENSION (2005)
Should β blockers remain first choice in the treatment of primary hypertension?: A meta-analysis
LH Lindholm et al.
LANCET (2005)
Prevention of cardiovascular events with an antihypertensive regimen of amlodipine adding perindopril as required versus atenolol adding bendroflumethiazide as required, in the Anglo-Scandinavian Cardiac Outcomes Trial-Blood Pressure Lowering Arm (ASCOT-BPLA):: a multicentre randomised controlled trial
B Dahlöf et al.
LANCET (2005)
The combination therapy of hypertension to prevent cardiovascular events (COPE) trial: Rationale and design
T Ogihara et al.
HYPERTENSION RESEARCH (2005)
Outcomes in hypertensive patients at high cardiovascular risk treated with regimens based on valsartan or amlodipine: the VALUE randomised trial
S Julius et al.
LANCET (2004)
Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
AV Chobanian et al.
HYPERTENSION (2003)
Cardiovascular prevention and blood pressure reduction: a quantitative overview updated until 1 March 2003
JA Staessen et al.
JOURNAL OF HYPERTENSION (2003)
Calcium antagonist, lacidipine slows down progression of asymptomatic carotid atherosclerosis -: Principal results of the European Lacidipine Study on Atherosclerosis (ELSA), a randomized, double-blind, long-term trial
A Zanchetti et al.
CIRCULATION (2002)
Trends in mortality from cardiovascular and cerebrovascular diseases in Europe and other areas of the world
F Levi et al.
HEART (2002)
Cardiovascular morbidity and mortality in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE):: a randomised trial against atenolol
B Dahlöf et al.
LANCET (2002)
Therapeutic approaches to achieve desired blood pressure goals: Focus on calcium channel blockers
S Koshy et al.
CARDIOVASCULAR DRUGS AND THERAPY (2000)
Share Paper
